Time trial: A prospective comparative study of the time-resource burden for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy in head and neck cancers

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 2, 2009, Pages 107-112

  Murthy, Vedang ^a   Gupta, Tejpal ^a   Kadam, Avinash ^a   Ghosh Laskar, Sarbani ^a   Budrukkar, Ashwini ^a   Phurailatpam, Reenadevi ^a   Pai, Rajeshri ^a   Agarwal, Jaiprakash ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Burden; Intensity modulated radiotherapy; Manpower; Person hours; Three dimensional conformal radiotherapy; Workload

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

ADULT; COHORT STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOTHERAPY;

EID: 67749116572     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.52800     Document Type: Article

References (19)

1. Chao KS, Deasy JO, Markman J, Haynie J, Perez CA, Purdy JA, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 2001;49:907-16.
2. Eisbruch A, Marsh LH, Dawson LA, Bradford CR, Teknos TN, Chepeha DB, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 2004;59:28-42.
3. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys 2003;57:49-60.
4. Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy
5. vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91.
6. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;63:410-21.
7. Baker CR, Hardy V. Provision of IMRT in the UK. Part 2: Current levels, planned expansion and obstacles to implementation. Journal of Radiotherapy in Practice 2003;3:181-4.
8. Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000;48:711-722.
9. van Dieren EB, Nowak PJ, Wijers OB, van Sornsen de Koste JR, van der Est H, et al. Beam intensity modulation using tissue compensators or dynamic multileaf collimation in three-dimensional conformal radiotherapy of primary cancers of the oropharynx and larynx, including the elective neck. Int J Radiat Oncol Biol Phys 2000;47:1299-309.
10. Bijdekerke P, Verellen D, Tournel K, Vinh-Hung V, Somers F, Bieseman P, et al. TomoTherapy: implications on daily workload and scheduling patients. Radiother Oncol 2008;86:224-30.
11. Hunt MA, Zelefsky MJ, Wolden S, Chui CS, LoSasso T, Rosenzweig K, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49:623-32.
12. Miles EA, Clark CH, Urbano MT, Bidmead M, Dearnaley DP, Harrington KJ, et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol 2005;77:241-6.
13. Munter MW, Thilmann C, Hof H, Didinger B, Rhein B, Nill S, et al. Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol 2003;66:313-21.
14. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. Radiother Oncol 2003;69:227-36.
15. Glatstein E. The return of the snake oil salesmen. Int J Radiat Oncol Biol Phys 2003;55:561-2.
16. Gillis S, De Wagter C, Bohsung J, Perrin B, Williams P, Mijnheer BJ. An inter-centre quality assurance network for IMRT verification: results of the ESTRO QUASIMODO project. Radiother Oncol 2005;76:340-53.
17. Palta JR, Liu C, Li JG. Quality assurance of intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 2008;71:S108-12.
18. Ozyigit G, Chao KS. Clinical experience of head-and-neck cancer IMRT with serial tomotherapy. Med Dosim 2002;27:91-8.
19. Takamiya R, Missett B, Weinberg V, Akazawa C, Akazawa P, Zytkovicz A, et al. Simplifying intensity-modulated radiotherapy plans with fewer beam angles for the treatment of oropharyngeal carcinoma. J Appl Clin Med Phys 2007;8:26-36.